U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07098663) titled 'Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes' on June 15.

Brief Summary: The goal of this intervention study is to evaluate the safety, tolerability and pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of MKP10241 in obese participants with and without T2DM in 3 parts. The main parameters it aims to answers are :

1. Does food effects the pharmacokinetic parameters following a single dose of MKP10241 in healthy participants?

2. Will multiple ascending doses of MKP10241 in obese participants with or without T2DM characterize changes in the plasma phar...